Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-008154

Zosano Pharma Corp · ZSAN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 30, 2015
Accepted (ET)
Feb 2, 2015 · 1:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 30, 2015C64,661$9.35A518,904IBy BMV Direct SO LP
Common StockF2Jan 30, 2015P26,543$11.00A545,447IBy BMV Direct SO LP
Common StockF1,F3Jan 30, 2015C317,409$9.35A1,896,982IBy BMV Direct SOTRS LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
8% Convertible Note Issued 9/9/13F2,F1—Jan 30, 2015C337,150D—Mar 31, 2015Common Stock337,1500I
8% Convertible Note Issued 9/9/13F3,F1—Jan 30, 2015C1,101,393D—Mar 31, 2015Common Stock1,101,3930I
8% Convertible Note Issued 2/26/14F2,F1—Jan 30, 2015C267,446D—Mar 31, 2015Common Stock267,4460I
8% Convertible Note Issued 2/26/14F3,F1—Jan 30, 2015C1,148,956D—Mar 31, 2015Common Stock1,148,9560I
8% Convertible Note Issued 12/2/14F3,F1—Jan 30, 2015C717,437D—Mar 31, 2015Common Stock717,4370I

Explanation of responses